Catheter-related complications of intraperitoneal chemotherapy as first-line treatment for advanced epithelial ovarian carcinoma

被引：0
|
作者：
Landrum, L. M. [1 ]
Gold, M. A. [1 ]
Mcmeekin, D. S. [1 ]
Walker, J. L. [1 ]
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Gynecol Oncol Sect, Oklahoma City, OK USA
来源：
GYNECOLOGIC ONCOLOGY | 2007年 / 107卷 / 02期
关键词：
D O I：
10.1016/j.ygyno.2007.08.029
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：368 / 369
页数：2
相关论文
共 50 条
  • [31] ADDITIONAL INTRAPERITONEAL CISPLATIN/ETOPOSIDE TO FIRST-LINE CHEMOTHERAPY IN ADVANCED EPITHELIAL OVARIAN CANCER: THEINTERIM ANALYSISOF A RANDOMIZED PHASE II STUDY
    Zang, R. Y.
    Yu, J. J.
    Dai, Z. Y.
    Jiang, R.
    Zhang, Y. Q.
    Wang, H. Y.
    Tang, J.
    Cheng, X.
    Cai, S. M.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [32] ADDITIONAL INTRAPERITONEAL CISPLATIN/ETOPOSIDE TO FIRST-LINE CHEMOTHERAPY IN ADVANCED EPITHELIAL OVARIAN CANCER: The PRELIMINARY ANALYSIS OF A RANDOMIZED PHASE II STUDY
    Jiang, R.
    Yu, J.
    Dai, Z.
    Shen, Y.
    Zhang, Y.
    Tu, R.
    Wang, H.
    Tang, J.
    Yang, H.
    Cheng, X.
    Tu, D.
    Jia, H.
    Cai, S.
    Zang, R.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 736 - 736
  • [33] A pharmacokinetic and clinical evaluation of thio-TEPA in combination with cisplatin as first-line chemotherapy for advanced epithelial ovarian carcinoma
    Hagen, B
    Onsrud, M
    Dale, O
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1999, 9 (02) : 110 - 116
  • [34] Completion of intraperitoneal chemotherapy is not catheter-related: A comparison of two catheter types
    Lesnock, J.
    Richard, S. D.
    McBee, W. C.
    Sukumvanich, P.
    Zom, K. K.
    Edwards, R. P.
    Krivak, T. C.
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S57 - S58
  • [35] First-line chemotherapy trial in advanced endometrial carcinoma
    Siqing Fu
    John J. Kavanagh
    [J]. Current Oncology Reports, 2004, 6 (6) : 483 - 483
  • [36] Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer
    Papadimitriou, CA
    Kouroussis, C
    Moulopoulos, LA
    Vlahos, G
    Rodolakis, A
    Kiamouris, C
    Diakomanolis, E
    Gika, D
    Michalas, S
    Dimopoulos, MA
    [J]. CANCER, 2001, 92 (07) : 1856 - 1863
  • [37] Modified Intraperitoneal Chemotherapy Without Bevacizumab as a First-Line Therapy for Newly Diagnosed Advanced Epithelial Ovarian Cancer-Two Centers Experiences
    Shen, Yuanming
    Tang, Sangsang
    Xu, Junfen
    Xie, Xing
    Chen, Zhongbo
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [38] Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trial
    Tingyan Shi
    Rong Jiang
    Jinjin Yu
    Huijuan Yang
    Dongsheng Tu
    Zhiyuan Dai
    Yang Shen
    Yuqin Zhang
    Xi Cheng
    Huixun Jia
    Ruiqin Tu
    Huaying Wang
    Jie Tang
    Yuting Luan
    Shumo Cai
    Rongyu Zang
    [J]. British Journal of Cancer, 2018, 119 : 12 - 18
  • [39] Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trial
    Shi, Tingyan
    Jiang, Rong
    Yu, Jinjin
    Yang, Huijuan
    Tu, Dongsheng
    Dai, Zhiyuan
    Shen, Yang
    Zhang, Yuqin
    Cheng, Xi
    Jia, Huixun
    Tu, Ruiqin
    Wang, Huaying
    Tang, Jie
    Luan, Yuting
    Cai, Shumo
    Zang, Rongyu
    [J]. BRITISH JOURNAL OF CANCER, 2018, 119 (01) : 12 - 18
  • [40] Bevacizumab in the First-line Treatment of advanced Ovarian Cancer
    Mallmann, Michael R.
    Alakus, Hakan
    Mallmann, Peter
    Bruns, Christiane
    [J]. ONKOLOGE, 2019, 25 (11): : 1020 - 1021
12345